This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through November 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
payments: Archive
Wall Street Ups Mastercard's Earnings View, But the Price Tag Bites
by Kaibalya Pravo Dey
MA's rising earnings outlook and global momentum fuel optimism, but premium valuation and mounting regulatory risks temper enthusiasm.
MAPositive Net Change VNegative Net Change AXPPositive Net Change
business-services finance payments
Kennametal (KMT) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
KMTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Think Visa's Q4 Was Good? Wait Till You See What's Under the Hood
by Kaibalya Pravo Dey
V's steady Q4 beat hides a deeper growth story; its expanding digital, tokenization and stablecoin ecosystem is reshaping payments.
MAPositive Net Change VNegative Net Change AXPPositive Net Change
business-services earnings-surprise finance payments
Is Block (XYZ) a 'Buy' Ahead of Its Upcoming Earnings Announcement?
by Bryan Hayes
The company remains vulnerable to intense competition from big names like PayPal.
XYZPositive Net Change
artificial-intelligence blockchain cryptocurrency earnings fin-tech investing payments software stock-performance tech-stocks
Should You Buy, Hold or Sell Affirm Stock Before Q1 Earnings Report?
by Kaibalya Pravo Dey
AFRM heads into its Q1 FY2026 report with strong revenue and earnings growth estimates, but its premium valuation will likely test investor patience.
VNegative Net Change PYPLPositive Net Change AFRMPositive Net Change
earnings-outlook earnings-preview fin-tech finance payments
Can Fidelity National Beat Q3 Earnings on Banking Solutions Strength?
by Zacks Equity Research
FIS heads into Q3 with steady estimates and strong Banking Solutions growth that could fuel another earnings beat.
MAPositive Net Change VNegative Net Change FISPositive Net Change WUPositive Net Change
business-services earnings finance payments
Will Higher Costs Spoil Global Payments' Q3 Earnings? Key Insights
by Zacks Equity Research
GPN is expected to post modest Q3 gains, as rising service and operating costs may limit profit growth.
MAPositive Net Change VNegative Net Change WUPositive Net Change GPNPositive Net Change
business-services earnings finance payments
MercadoLibre Q3 Earnings Miss Estimates, Revenues Rise Y/Y
by Zacks Equity Research
MELI's Q3 earnings miss estimates despite 39.5% revenue growth, fueled by strong commerce and fintech momentum.
MELINegative Net Change CPRIPositive Net Change FVRRNegative Net Change FWRGNegative Net Change
earnings fin-tech payments retail tech-stocks
Visa Q4 Earnings Beat Estimates on Processed Transactions
by Zacks Equity Research
V's Q4 earnings and revenues top estimates as processed transactions and cross-border volumes surge despite higher costs.
VNegative Net Change RELYPositive Net Change PAGSPositive Net Change CPAYPositive Net Change
business-services earnings fin-tech finance payments
EastGroup Properties (EGP)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
EGPPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Mastercard's Pre-Earnings Reality Check: Buy, Sell or Hold Before Q3?
by Kaibalya Pravo Dey
MA prepares for its Q3 results with double-digit growth forecasts, rising costs and a premium valuation testing investor confidence.
MAPositive Net Change VNegative Net Change AXPPositive Net Change
business-services earnings-outlook earnings-preview finance payments
Cash is Old School, Code is Cool: Top Mobile Payment Stocks to Buy
by Kaibalya Pravo Dey
From AI-driven wallets to QR-enabled dining, mobile payments are redefining money movement. Meet the four stocks leading the charge.
COFPositive Net Change AFRMPositive Net Change MQPositive Net Change VYXPositive Net Change
e-commerce fin-tech finance payments thematic
After Golden Cross, Aaon (AAON)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AAONPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Visa Poised for a Q4 Surprise as Volumes Soar: Buy Before the Beat?
by Kaibalya Pravo Dey
V eyes a strong Q4 as payment volumes surge and key transaction metrics point to another earnings beat.
MAPositive Net Change VNegative Net Change AXPPositive Net Change
business-services earnings-outlook earnings-preview finance payments
Euronet Q3 Earnings Beat Estimates on Digital Transformation Efforts
by Zacks Equity Research
EEFT's Q3 earnings rose 19% year over year to $3.62 per share, beating estimates on strong digital and global expansion initiatives.
AONNegative Net Change EEFTPositive Net Change WTWNegative Net Change HOODNegative Net Change
earnings fin-tech finance payments
Payments Kings Duel: Can American Express Outclass Mastercard?
by Kaibalya Pravo Dey
MA's asset-light model, global reach and innovation edge give it a decisive lead over AXP in the payments race.
MAPositive Net Change AXPPositive Net Change
business-services fin-tech finance payments
Allegiant Travel (ALGT) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
ALGTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy BlackBerry (BB) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
BBNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Beam Therapeutics Inc. (BEAM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
BEAMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Affirm & Fanatics Team Up to Offer Flexible Payments for Sports Fans
by Zacks Equity Research
AFRM joins forces with Fanatics to bring fans flexible, transparent payment options for sports gear and collectibles.
MAPositive Net Change VNegative Net Change PYPLPositive Net Change AFRMPositive Net Change
fin-tech payments
Visa vs. Affirm: Can the BNPL Rebel Charge Past the Credit Card King?
by Kaibalya Pravo Dey
AFRM's data-driven BNPL surge and 55% stock jump challenge V's global dominance as payments enter a new era of digital disruption.
MAPositive Net Change VNegative Net Change AFRMPositive Net Change KLARPositive Net Change
business-services credit-card fin-tech finance payments
American Express Q3 Earnings Beat Estimates on Rising Network Volume
by Zacks Equity Research
AXP delivers a 19% EPS jump and double-digit revenue growth in Q3 2025, fueled by record network volumes and resilient card fee income.
AXPPositive Net Change STTPositive Net Change UFCSPositive Net Change JHGPositive Net Change
earnings fin-tech finance payments
Ericsson (ERIC) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ERICNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Karyopharm Therapeutics (KPTI)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
KPTIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can Mastercard & U.S. Bank Simplify the Subscription Overload?
by Zacks Equity Research
MA deepens its digital role through a U.S. Bank partnership that simplifies subscription tracking for cardholders.
MAPositive Net Change VNegative Net Change PYPLPositive Net Change
business-services fin-tech finance payments